期刊簡介預計審稿時間： 約2月

Helicobacter is edited by Professor David Y Graham. The editorial and peer review process is an independent process. Whenever there is a conflict of interest, the editor and editorial board will declare their interests and affiliations. Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of gastroenterology; microbiology; vaccine development; laboratory animal science.

《幽門螺桿菌》由 David Y Graham 教授編輯。編輯和同行評審過程是一個獨立的過程。當存在利益沖突時，編輯和編輯委員會將聲明其利益和從屬關系。《幽門螺桿菌》承認幽門螺桿菌在消化性潰瘍、胃腺癌和原發(fā)性胃淋巴瘤中起著關鍵作用。由于現在經常發(fā)現新的幽門螺桿菌種，《幽門螺桿菌》涵蓋了幽門螺桿菌研究的整個范圍，增加了胃腸病學、微生物學、疫苗開發(fā)、實驗室動物科學等領域之間的交流。

《Helicobacter》(幽門螺桿菌)編輯部通訊方式為WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。